B53.8
Other malaria, not elsewhere classified
Clinical Classification Guidelines
Medical Intelligence & Overview
Other malaria, classified under ICD-10 code B53.8, refers to cases of malaria that do not fall into the more common categories such as Plasmodium falciparum or Plasmodium vivax malaria. This category includes less typical or atypical forms of malaria caused by different Plasmodium species or unusual presentations of the disease. Malaria remains a significant global health concern, especially in tropical and subtropical regions, and understanding its various forms can assist in better recognition and management.
Causes & Symptoms
Clinical Causes: Infection by less common Plasmodium species, such as Plasmodium ovale, Plasmodium malariae, or Plasmodium knowlesi. Unusual strains or mutations of typical malaria parasites. Reinfection or relapse of malaria from dormant liver stages. Transmission through contaminated mosquito bites, especially in endemic areas. Less frequently, through blood transfusions or sharing contaminated needles.
Key Symptoms: Fever and chills, often recurring in cycles. Sweating episodes following fever spikes. Headaches and muscle aches. Fatigue and weakness. Nausea, vomiting, and abdominal discomfort. Mild symptoms that can progress to severe anemia or organ complications if untreated.
Diagnostic & Treatment
Diagnosis Path: Diagnosis primarily involves blood tests, including microscopic examination of blood smears to identify the parasite species. Rapid diagnostic tests (RDTs) are also widely used for quick detection. Due to the variety of species involved in other malaria types, precise identification helps guide appropriate treatment. Additional tests like PCR (polymerase chain reaction) may be utilized for confirmation, especially in atypical or unclear cases.
Treatment Protocols: Treatment depends on the specific Plasmodium species identified and the severity of the infection. Common antimalarial medications include chloroquine, quinine, doxycycline, or combination therapies like artemisinin-based combination therapies (ACTs). In some cases, supportive care to manage symptoms and prevent complications is necessary. Resistance patterns in certain regions may influence treatment choices, emphasizing the importance of tailored therapy guided by healthcare professionals.
Clinical Advice & FAQs
Billing Guidance
Is B53.8 a billable ICD-10 code?
Yes, B53.8 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B53.8?
Clinical documentation must specify the nature of Other malaria, not elsewhere classified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference